Written Question·Department of Health and Social Care·UIN 29367

Cerliponase Alfa

Tabled: 5 February 2025

Answered: 10 February 2025

Named Day

Question

Adam Dance

To ask the Secretary of State for Health and Social Care, what progress has been made on the negotiations with Biomarine on the provision of Brineura as a treatment for Batten disease.

Answer

Karin Smyth

The National Institute for Health and Care Excellence (NICE) is currently developing guidance for the National Health Service on whether Brineura (cerliponase alfa) can be recommended for routine NHS funding, taking into account real-world evidence collec...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 29367) →